Srivastava Deepak
Known title: DirectorCIK: 0001868501
Srivastava Deepak's purchase track record
Srivastava Deepak has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/21/2022 | TNYA | $600K | +36.9% | +219.3% | +6.1% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| TNYA | ▲ Buy | Open Market | 230,769 | $600K | 11/21/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
Tenaya Therapeutics noted among health‑care stocks moving intraday
Tenaya Therapeutics was listed among twelve health‑care stocks that showed notable intraday movement on Wednesday, according to Benzinga. The activity reflects broader sector momentum and comes while the stock is in oversold territory (RSI 19.6) and near its $0.68 support level.
Tenaya Therapeutics noted among health‑care stocks moving intraday. Tenaya Therapeutics was listed among twelve health‑care stocks that showed notable intraday movement on Wednesday, according to Benzinga. The activity reflects broader sector momentum and comes while the stock is in oversold territory (RSI 19.6) and near its $0.68 support level.